na
purif
pcrrevers
transcript
rt
pcr
gold
standard
molecular
diagnost
magna
pure
system
roch
molecular
biochem
indianapoli
indiana
unit
state
us
wide
use
system
highthroughput
na
purif
mani
public
health
laboratori
worldwid
howev
roch
announc
emerg
kitshortag
bottleneck
kit
product
process
investig
realtim
rtpcr
rtqpcr
analysi
could
perform
minim
pretreat
sampl
use
common
sampl
type
oropharyng
swab
collect
patient
suspect
denmark
three
simplifi
approach
involv
minim
handl
sampl
rtqpcr
employ
avoid
na
purif
step
first
approach
direct
salinetransport
solut
throatswab
ad
rtqpcr
reaction
without
treatment
second
phosphatebuff
salin
pb
dilut
approach
salinetransport
solut
dilut
pb
ad
directli
rtqpcr
reaction
third
heatprocess
method
compar
four
differ
heatprocess
salinetransport
solut
throat
swab
min
ii
min
iii
min
iv
min
respect
heatprocess
clinic
sampl
cool
min
use
rtqpcr
reaction
two
rtqpcr
assay
use
publish
wide
use
rtqpcr
assay
envelop
e
gene
combin
sensifast
probe
norox
onestep
realtim
pcr
kit
biolin
meridian
bioscienc
cincinnati
ohio
us
ii
commerci
realstar
rtpcr
kit
altona
diagnost
hamburg
germani
employ
patient
sampl
compris
posit
neg
rtqpcr
result
number
posit
cycl
threshold
ct
valu
differ
approach
compar
rtqpcr
result
magna
pure
qiacub
connect
qiagen
hilden
germani
purifi
sampl
switch
magna
pure
qiacub
connect
system
extract
na
necessari
due
shortag
process
cartridg
magna
pure
system
posit
sampl
sampl
purifi
magna
pure
system
sampl
qiacub
connect
system
sampl
purifi
use
na
extract
method
comparison
sensifast
probe
norox
onestep
realtim
pcr
result
use
simplifi
workflow
na
purif
system
shown
tabl
tabl
figur
posit
neg
oropharyng
swabsampl
heatprocess
min
rtqpcr
reaction
show
sensit
specif
accuraci
compar
magna
pure
purifi
sampl
use
sensifast
assay
tabl
simplifi
approach
show
lower
sensit
specif
accuraci
compar
qiacub
connect
purifi
sampl
magna
pure
purifi
sampl
falseposit
detect
observ
two
nonheat
sampl
ct
ct
one
patient
sampl
purifi
use
qiacub
connect
system
came
posit
ct
tabl
could
confirm
result
either
repetit
use
qiacub
connect
purif
system
magna
pure
system
heat
process
could
reflect
detect
limit
rtqpcr
assay
extract
method
sensifast
assay
heatprocess
min
sampl
show
minor
differ
median
ct
valu
differ
compar
magna
pure
extract
sampl
tabl
figur
analysi
median
ct
valu
interquartil
rang
iqr
detect
nondetect
sampl
shown
tabl
sampl
detect
tendenc
toward
high
ct
valu
pattern
conclus
contrast
realstar
rtpcr
reaction
notabl
inhibit
addit
oropharyng
swab
sampl
without
na
extract
heattreat
treatment
indic
rtpcr
kit
compat
simplifi
heatprocess
method
data
shown
newli
emerg
viru
challeng
global
health
system
everi
aspect
includ
abil
provid
suffici
reagent
molecular
diagnost
test
overcom
shorten
suppli
computeris
tomographi
ct
scan
lung
use
diagnosi
mix
result
risk
falseneg
especi
earli
onset
symptom
period
shortag
diagnost
kit
china
occur
chines
health
institut
resort
diagnos
patient
base
clinic
symptom
alon
result
major
peak
report
case
februari
clinic
symptom
sometim
nonspecif
cough
mild
fever
sore
throat
fatigu
similar
respiratori
diseas
even
absent
despit
infect
molecular
test
necessari
accur
diagnosi
diagnost
laboratori
purif
oropharyng
swab
patient
usual
perform
use
magna
pure
system
diagnosi
subsequ
perform
use
sensifast
rtqpcr
assay
due
alarmingli
low
access
na
purif
reagent
kit
show
altern
magna
pure
purif
step
simpl
heat
min
result
sensit
specif
accuraci
ci
ci
ci
respect
use
sensifast
rtqpcr
assay
supplementari
data
context
studi
sensifast
rtqpcr
assay
gave
accept
result
nonpurifi
materi
assay
use
realstar
rtqpcr
kit
seem
inhibit
minimallyprocess
sampl
due
differ
rtqpcr
assay
recommend
rtqpcr
assay
use
togeth
heatprocess
workflow
valid
implement
clinic
diagnost
also
underlin
heat
oropharyng
swab
min
follow
cool
min
rtqpcr
reaction
sensit
accur
rtqpcr
reaction
perform
purifi
sampl
even
though
find
consider
differ
ctvalu
heatprocess
sampl
na
extract
sampl
rule
possibl
rna
degrad
heat
simplifi
heatapproach
gener
use
gold
standard
approach
avail
case
reagent
na
purif
limit
due
pandem
simpli
heat
sampl
could
serv
easi
fast
inexpens
altern
chemic
extract
kit
would
detect
patient
fals
posit
howev
might
small
risk
fals
neg
could
minimis
perform
assay
duplic
exempt
review
ethic
committe
system
inform
consent
given
committe
biomed
research
ethic
capit
region
accord
danish
law
assay
develop
project
